Back
Spyre Therapeutics Stock Price Chart
Sponsored
SYRE
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
44
SYRE
Spyre Therapeutics
Last Price:
34.37
Seasonality Move:
2.92%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- The current trend is moderately bearish and SYRE is experiencing slight selling pressure.
Spyre Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.68 | Sell |
20-day SMA: | 35.03 | Sell |
50-day SMA: | 36.35 | Sell |
200-day SMA: | 21.16 | Buy |
8-day EMA: | 34.78 | Sell |
20-day EMA: | 35 | Sell |
50-day EMA: | 33.95 | Buy |
200-day EMA: | 24.71 | Buy |
Spyre Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 47.44 | Sell |
Chaikin Money Flow: | -56429 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.42 - 37.22) | Sell |
Bollinger Bands (100): | (21.37 - 37.29) | Buy |
Spyre Therapeutics Technical Analysis
Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spyre Therapeutics Stock
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 34.25 while SYRE 8-day simple moving average is 34.68, which is a Sell signal.
- The stock price of SYRE is 34.25 while Spyre Therapeutics 20-day SMA is 35.03, which makes it a Sell.
- Spyre Therapeutics 50-day simple moving average is 36.35 while SYRE share price is 34.25, making it a Sell technically.
- SYRE stock price is 34.25 and Spyre Therapeutics 200-day simple moving average is 21.16, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Sell
44
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a Sell
The current Spyre Therapeutics [SYRE] share price is $34.25. The Score for SYRE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Spyre Therapeutics Stock Info
Market Cap:
1.24B
Price in USD:
34.25
Share Volume:
175.6K
Spyre Therapeutics 52-Week Range
52-Week High:
47.97
52-Week Low:
2.66
Sell
44
Spyre Therapeutics (SYRE)
is a Sell
Spyre Therapeutics Share Price Forecast
-
What is the Spyre Therapeutics stock price today?
The Spyre Therapeutics stock price is 34.25 USD today. -
Will SYRE stock go up or go down?
Spyre Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spyre Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics is overvalued.
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 34.25 while SYRE 8-day exponential moving average is 34.78, which is a Sell signal.
- The stock price of SYRE is 34.25 while Spyre Therapeutics 20-day EMA is 35.00, which makes it a Sell.
- Spyre Therapeutics 50-day exponential moving average is 33.95 while SYRE share price is 34.25, making it a Buy technically.
- SYRE stock price is 34.25 and Spyre Therapeutics 200-day simple moving average is 24.71, creating a Buy signal.
Fundamental Analysis of Spyre Therapeutics
Is Spyre Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.42 per share, an increase this year of $10.15 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Spyre Therapeutics
Should I short Spyre Therapeutics stock?
- SYRE Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Spyre Therapeutics is a Sell
- Spyre Therapeutics Relative Strength Index (RSI) is 47.44, which suggest Spyre Therapeutics is oversold
- The Bollinger Bands (25) for Spyre Therapeutics is (33.42 - 37.22), which suggest Spyre Therapeutics is a Buy
- The Bollinger Bands (100) for Spyre Therapeutics is (21.37 - 37.29), which suggest Spyre Therapeutics is a Buy
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.